Collaborating to conquer Alzheimer’s disease

LifeArc is supporting MRC scientists who want to see their discoveries go from bench to bedside Age-related…

Life, re-engineered: new milestone in the emerging field of synthetic genomics

When MRC researchers achieved a new milestone in the emerging field of synthetic genomics, LifeArc set this…

Modelling the human brain

Candidate drugs to treat the central nervous system could be screened with three-dimensional brain tissue grown in…

Joining the fight against tuberculosis

The World Health Organisation estimates around 10 million people across the world acquired tuberculosis (TB) in 2017.…

Alliance enables clinical trial of experimental treatment for epidermolysis bullosa

An experimental medicine to treat the rare inherited skin disorder epidermolysis bullosa (EB) is on track to…

Keytruda: a new generation of cancer treatment

In 2007, LifeArc entered a collaboration with Organon - ultimately acquired by Merck - to translate innovative…

Childhood cancers: smaller charities campaigning for new treatments

The genetic abnormalities that lead to cancer can occur at any age. Cancer is the major cause…

Jump starting research: SpringWorks Therapeutics – unlocking science

LifeArc's joint venture with Pfizer, Bain Capital and OrbiMed With a purpose of working in partnership with…

Fighting antibiotic resistance

A new approach to identifying antibacterial drug targets With the rapid increase in multi-drug-resistant (MDR) gram-negative bacteria,…